Public Health
Johnson & Johnson’s COVID-19 vaccine reaches final trial stage
Johnson & Johnson’s COVID-19 vaccine isn’t the first to reach the final human trial stage, but it may have several advantages over its predecessors.
Studying pig sh*t to prevent the next pandemic
A pilot program in North Carolina offers one solution to scanning for a potential pig virus in our farm system - slurry testing.
This edible sensor can alert you of food contamination
A microneedle patch made of silk changes color if it senses food contamination or spoilage, making it easier to know when food’s gone bad.
What we know about COVID-19 reinfection so far
Researchers have reported four cases of COVID-19 reinfection, with patients recovering from the coronavirus and later testing positive for another strain.
A patient’s sex may affect their COVID-19 immune response
Key differences in the COVID-19 immune response of men and women could potentially explain a disparity in patient outcomes.
Influenza virus may be transmitted by particles in the air
Airborne particles like dust and dander not caused by breathing — “aerosolized fomites” — may be a route of influenza virus transmission.
$5 COVID-19 test could be a game changer in the US
Abbott Laboratories’ $5 COVID-19 test has secured an FDA authorization, meaning the U.S. now has access to a fast, accurate antigen test.
“Antivitamins” could be the cure for antibiotic resistance
The B1 antivitamin helps bacteria kill competing bacteria, leading researchers to suspect it could help us fight antibiotic resistance and superbugs.
Open-source COVID-19 saliva test could be a game changer
SalivaDirect, a COVID-19 saliva test funded by the NBA and NBA players’ union, could be the cheap, accurate testing method the U.S. desperately needs.
Gates Foundation backs a $3 coronavirus vaccine
The Gates Foundation is spending $150 million to help with the manufacturing and distribution of a $3 coronavirus vaccine in lower-income nations.